Scientists at the UCSF-affiliated Gladstone Institutes have devised a new molecular sensor that can detect MS at its earliest stages, even before the onset of physical signs.
UC San Francisco’s Health eHeart Study – an ambitious technology-based cardiovascular research study – has garnered the support from the American Heart Association, the largest U.S. non-profit organization dedicated to reducing disability and deaths caused by cardiovascular disease and stroke.
UCSF has been awarded a major federal grant to “transform and revolutionize” the treatment of prostate cancer, the second most common form of cancer among American men.
Technology and health care often go hand in hand, and UC San Francisco highlighted this budding alliance at the 11th annual Dreamforce conference, hosted by cloud computing giant Salesforce.com.